🔬 Health & Fitness Research
The Osteoboost Belt cleared the FDA with an 83% reduction in spine bone-strength loss—impressive on paper, but bone experts are skeptical: local spinal improvements won’t solve a systemic problem, and the study never tested fracture risk.
Marty’s Take:
The Osteoboost Belt marks a genuine category shift — from wearables that track health to wearables that treat it. FDA clearance and peer-reviewed clinical data is the template every health-focused startup will chase: condition-specific, reimbursable, and prescribed by doctors. The best fitness trackers today compete on step counts and HRV; the real value unlock over the next 12 months is therapeutic hardware that earns a place in a clinical workflow.
Source: NPR
